NOVAVAX INC's ticker is and the CUSIP is 670002AB0. A total of 35 filers reported holding NOVAVAX INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $39,342 | -99.9% | 39,500,000 | 0.0% | 1.08% | +99.1% |
| Q3 2022 | $38,710,000 | -29.6% | 39,500,000 | -31.3% | 0.54% | -88.4% |
| Q2 2020 | $55,010,000 | +187.3% | 57,513,000 | +135.1% | 4.68% | +128.5% |
| Q1 2020 | $19,146,000 | +47.2% | 24,468,000 | -23.8% | 2.05% | +42.5% |
| Q4 2019 | $13,008,000 | -3.0% | 32,118,000 | 0.0% | 1.44% | -26.6% |
| Q3 2019 | $13,410,000 | +4.4% | 32,118,000 | 0.0% | 1.96% | +130.4% |
| Q2 2019 | $12,847,000 | +9.0% | 32,118,000 | 0.0% | 0.85% | +134.8% |
| Q1 2019 | $11,784,000 | -35.8% | 32,118,000 | +7.1% | 0.36% | -33.2% |
| Q4 2018 | $18,354,000 | -0.3% | 30,000,000 | 0.0% | 0.54% | +24.0% |
| Q3 2018 | $18,413,000 | +52.6% | 30,000,000 | +46.7% | 0.44% | +79.8% |
| Q2 2018 | $12,066,000 | -21.0% | 20,450,000 | -5.5% | 0.24% | -1.6% |
| Q1 2018 | $15,265,000 | +64.8% | 21,650,000 | +11.0% | 0.25% | +49.7% |
| Q4 2017 | $9,263,000 | +32.8% | 19,500,000 | +30.0% | 0.16% | +58.7% |
| Q3 2017 | $6,975,000 | +204.9% | 15,000,000 | +200.0% | 0.10% | +215.2% |
| Q1 2017 | $2,288,000 | – | 5,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Graham Capital Management, L.P. | 65,636,000 | $117,228,000 | 6.14% |
| WHITEBOX ADVISORS LLC | 34,014,000 | $60,630,000 | 1.23% |
| Saltoro Capital, LP | 1,500,000 | $2,689,000 | 1.09% |
| DeepCurrents Investment Group LLC | 19,500,000 | $35,011,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 25,000,000 | $44,647,000 | 0.79% |
| CSS LLC/IL | 9,250,000 | $16,583,000 | 0.69% |
| WOLVERINE ASSET MANAGEMENT LLC | 48,772,000 | $87,240,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 2,914,000 | $5,198,000 | 0.34% |
| LINDEN ADVISORS LP | 27,403,000 | $48,980,000 | 0.26% |
| PFM Health Sciences, LP | 4,250,000 | $7,612,000 | 0.24% |